This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Livneh, E Articles by Schlessinger, J Search for Related Content PubMed PubMed Citation Articles by Livneh, E Articles by Schlessinger, J

Release of a phorbol ester-induced mitogenic block by mutation at Thr-654 of the epidermal growth factor receptor.

Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.

ABSTRACT

The tumor promoter phorbol ester (TPA) modulates the binding affinity and the mitogenic capacity of the epidermal growth factor (EGF) receptor. Moreover, TPA-induced kinase C phosphorylation occurs mainly on Thr-654 of the EGF receptor, suggesting that the phosphorylation state of this residue regulates ligand-binding affinity and kinase activity of the EGF receptor. To examine the role of this residue, we prepared a Tyr-654 EGF receptor cDNA construct by in vitro site-directed mutagenesis. Like the wild-type receptor, the mutant receptor exhibited typical high- and low-affinity binding sites when expressed on the surface of NIH 3T3 cells. Moreover, TPA regulated the affinity of both wild-type and mutant receptors and stimulated receptor phosphorylation of serine and threonine residues other than Thr-654. The addition of TPA to NIH 3T3 cells expressing a wild-type human EGF receptor blocked the mitogenic capacity of EGF. However, this inhibition did not occur in cells expressing the Tyr-654 EGF receptor mutant. In the latter cells, EGF was able to stimulate DNA synthesis even in the presence of inhibitory concentrations of TPA. While phosphorylation of sites other than Thr-654 may regulate ligand-binding affinity, the phosphorylation of Thr-654 by kinase C appears to provide a negative control mechanism for EGF-induced mitogenesis in mouse NIH 3T3 fibroblasts.

This article has been cited by other articles:

• Wang, X.-q., Yan, Q., Sun, P., Liu, J.-W., Go, L., McDaniel, S. M., Paller, A. S. (2007). Suppression of Epidermal Growth Factor Receptor Signaling by Protein Kinase C-{alpha} Activation Requires CD82, Caveolin-1, and Ganglioside. Cancer Res. 67: 9986-9995 [Abstract] [Full Text]  
• Sengupta, P., Ruano, M. J., Tebar, F., Golebiewska, U., Zaitseva, I., Enrich, C., McLaughlin, S., Villalobo, A. (2007). Membrane-permeable Calmodulin Inhibitors (e.g. W-7/W-13) Bind to Membranes, Changing the Electrostatic Surface Potential: DUAL EFFECT OF W-13 ON EPIDERMAL GROWTH FACTOR RECEPTOR ACTIVATION. J. Biol. Chem. 282: 8474-8486 [Abstract] [Full Text]  
• Wang, Y.-H., Jue, S. F., Maurer, R. A. (2000). Thyrotropin-Releasing Hormone Stimulates Phosphorylation of the Epidermal Growth Factor Receptor in GH3 Pituitary Cells. Mol. Endocrinol. 14: 1328-1337 [Abstract] [Full Text]  
• Mineo, C., Gill, G. N., Anderson, R. G. W. (1999). Regulated Migration of Epidermal Growth Factor Receptor from Caveolae. J. Biol. Chem. 274: 30636-30643 [Abstract] [Full Text]  
• Ouyang, X., Gulliford, T., Zhang, H., Huang, G. C., Epstein, R. (1996). Human Cancer Cells Exhibit Protein Kinase C-dependent c-erbB-2 Transmodulation That Correlates with Phosphatase Sensitivity and Kinase Activity. J. Biol. Chem. 271: 21786-21792 [Abstract] [Full Text]  
• Factor, V. M., Laskowska, D., Jensen, M. R., Woitach, J. T., Popescu, N. C., Thorgeirsson, S. S. (2000). Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model. Proc. Natl. Acad. Sci. USA 97: 2196-2201 [Abstract] [Full Text]